Table 1.
Country | Source | Years | Variation of incidence (APC) | ||
---|---|---|---|---|---|
Females | Males | ||||
Australia | [27] (Patients aged 15–30 years) | 1982 1982 2000 |
2007 2000 2007 |
— 2.0 13.8 |
4.0 — — |
Canada | [28] [29] |
1970/72 2002 |
1994/96 2008 |
3.5* 7.3 |
3.2* 8.4 |
China (Shanghai) | [30] | 1983 1983 |
2000 2003 |
— 4.9 |
2.6 — |
Denmark | [2] | 1973/1977 | 1998/2002 | 81.3%‡ | 20.0%‡ |
Finland | [2] | 1973/1977 | 1998/2002 | 62.8%‡ | 29.4%‡ |
France | [31] | 1983 | 2000 | 8.98 | 8.13 |
Israel-Jews | [2] | 1973/1977 | 1998/2002 | 95.2%‡ | 34.6%‡ |
Italy | [4] | 1991/95 | 2001/05 | 145%‡ | 127%‡ |
Japan | [2] | 1973/1977 | 1998/2002 | 85.7%‡ | 52.4%‡ |
Spain | [10] (Only PTCs) | 1978 | 2001 | 9.4§ | 2.6§ |
Switzerland | [2] | 1973/1977 | 1998/2002 | 85.7%‡ | 5.3%‡ |
UK | http://info.cancerresearchuk.org/cancerstats/ | 1993 | 2008 | 2.3 | 0.6 |
USA | [12] http://seer.cancer.gov/statfacts/html/thyro.html |
1998 1997 |
2005 2009 |
7.0 7.0 |
6.3 — |
APC: annual percent change.
*Average annual percent increase.
‡Percent temporal change (% increase) in the indicated period.
§Incidence increase in the indicated period.